Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.12 – $0.85
11% from low
Exchange
OTC Link
CS
Borrow rate
6.49%
Hard to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | $16.5M | $6.2M | $42.1M | $52.0M | $33.2M | $13.0M | $14.9M |
| Cost of revenue | $6.1M | $3.5M | $31.1M | $35.1M | $19.2M | $6.8M | $8.9M |
| Gross profit | $10.3M | $2.6M | $11.0M | $16.9M | $14.0M | $6.2M | $6.0M |
| Gross margin | 62.8% | 42.9% | 26.2% | 32.5% | 42.1% | 47.8% | 40.3% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$34.9M | −$36.6M | −$38.3M | −$193.8M | −$12.6M | $5.4M | −$7.4M |
| EBITDA | −$27.7M | −$1.8M | −$30.1M | −$171.6M | −$2.3M | $22.0M | −$6.3M |
| Net income | −$46.9M | −$30.1M | −$31.3M | −$188.9M | −$14.1M | $33.1M | −$8.0M |
| Net margin | -284.6% | -488.8% | -74.2% | -363.2% | -42.5% | 254.8% | -53.4% |
| EPS (diluted) | -44.26 | -15.69 | -8.30 | -32.04 | -1.72 | 2.47 | -0.60 |
Annual figures · source: Financial Modeling Prep
BLUM HOLDINGS INC.
No one on the platform currently holds BLMH.
No tracked institution reports a position in BLMH as of their last filing.
No one on the platform has traded BLMH yet.
| $3M |
| — |
| EGRXEagle Pharmaceuticals, Inc. | $0.67 | +11.67% | $9M | — |
| MCUJFMedicure Inc. | $0.67 | +0.00% | $7M | — |
Source: Financial Modeling Prep · peers by sector/industry
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.